Precipio, Inc. (PRPO) Earnings Call Transcripts
Precipio, Inc.'s Latest Earnings Call - Q4 FY2025
Precipio, Inc. reported its Q4 2025 and fiscal year 2025 results, highlighting a significant transition to a self-sustaining business with positive cash flow. The company achieved $24 million in revenue for FY 2025, a 30% increase year-over-year, driven by growth in the Pathology Services division. Gross margins improved to 45% from 41% in 2024. Management did not provide specific forward guidance but emphasized a focus on growth and execution in 2026, particularly in the Products division.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $24 million (beat) |
| Gross Margin | 45% (beat) |
| Products Division Gross Margin | 90% in Q4 (beat) |
| Pathology Services Revenue Mix | 90% (neutral) |
Guidance from management
Management did not provide specific numerical guidance but emphasized a focus on growth and execution in 2026, particularly in the Products division.
What analysts pressed on
Analysts expressed concerns about the Products division's growth challenges, particularly the operational fluctuations and limited commercial team that hindered expected revenue growth.
Main topics on the call
- Revenue Growth — Precipio reported $24 million in revenue for FY 2025, a 30% increase year-over-year, primarily driven by the Pathology Services division. Management highlighted 'continued expansion' and 'strengthening demand' as key fac...
- Gross Margin Improvement — Gross margins improved from 41% in 2024 to 45% in 2025, attributed to higher case volumes and a favorable case mix. The Products division saw a Q4 gross margin leap to 90% due to concentrated production runs.
- Products Division Challenges — The Products division did not grow as expected due to customer operational fluctuations and a limited commercial team. Management has since strengthened the team, hiring a Chief Commercial Officer and two business develo...
- Operational Leverage — Precipio emphasized operational leverage, noting that 'incremental revenue can be absorbed efficiently' due to a fixed cost structure, leading to improved margins and cash flow.
Read the full Precipio, Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Precipio, Inc.
Precipio, Inc. (PRPO) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 26 calls on record spanning January 20, 2020 to May 18, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 26 Precipio, Inc. earnings call transcripts on record, spanning January 20, 2020 to May 18, 2026. Based on this history, Precipio, Inc. reports quarterly. The most recent call on file is dated May 18, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- PRPO
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Calls on record
- 26
- First call
- January 20, 2020
- Most recent
- May 18, 2026
- Reporting cadence
- quarterly